We previously reported that ITD-Flt3 mutations found in ~25–30% of patients with acute myeloid leukemia (AML) and strongly associated with poor prognosis [12–14], increase expression of Survivin. The gene discussed is FLT3; the disease is acute myeloid leukemia.